ID
35690
Description
Study ID: 101468/192 Clinical Study ID: 101468/192 Study Title:A 52 Week Open-Label Extension Study of the Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The study consists of 16 visits which are devided in 3 study books: Book 1: Screening (+Baseline), Day 2, Week 1, Week 2 , Week 3 , Week 4, Week 5, Week 6, Week 7, Week 8 Book 2: Week 12, Week 24, Week 36, Week 48, Week 52, Follow-up Book 3: Early withdrawal and Follow-up Each follow-up Visit takes place 7 +/- 3 days after last dose This document contaisn the CRF Tracking/ Review Form (TRF) Study Conclusion form. It has to be filled in for the end of study.
Keywords
Versions (2)
- 8/28/17 8/28/17 -
- 3/15/19 3/15/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
March 15, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS), 101468/192
CRF Tracking/ Review Form (TRF) Study Conclusion
- StudyEvent: ODM
Description
CRF TRACKING/REVIEW FORM (TRF)
Alias
- UMLS CUI-1
- C3258859
Description
Investigator
Data type
text
Alias
- UMLS CUI [1]
- C2826892
Description
Screening Failure
Data type
boolean
Alias
- UMLS CUI [1]
- C1512714
Description
Module Description: Wk 12 - Wk 24 to Cont/Wthd
Data type
text
Alias
- UMLS CUI [1]
- C1709061
Description
pages
Data type
text
Alias
- UMLS CUI [1]
- C1548329
Description
Module Description: Wk 12
Data type
text
Alias
- UMLS CUI [1]
- C1709061
Description
pages
Data type
text
Alias
- UMLS CUI [1]
- C1548329
Description
Module Description: Wk 24
Data type
text
Alias
- UMLS CUI [1]
- C1709061
Description
pages
Data type
text
Alias
- UMLS CUI [1]
- C1548329
Description
Module Description: Wk 12 - Wk 24 RLS Scale
Data type
text
Alias
- UMLS CUI [1]
- C1709061
Description
pages
Data type
text
Alias
- UMLS CUI [1]
- C1548329
Description
Module Description: Wk 12 - Wk 24 Patient Rating Scale
Data type
text
Alias
- UMLS CUI [1]
- C1709061
Description
pages
Data type
text
Alias
- UMLS CUI [1]
- C1548329
Description
Module Description: Serious Adverse Experiences
Data type
text
Alias
- UMLS CUI [1]
- C1709061
Description
pages
Data type
text
Alias
- UMLS CUI [1]
- C1548329
Description
Module Description: Serious Adverse Experiences
Data type
text
Alias
- UMLS CUI [1]
- C1709061
Description
pages
Data type
text
Alias
- UMLS CUI [1]
- C1548329
Description
Module Description: Form D
Data type
text
Alias
- UMLS CUI [1]
- C1709061
Description
pages
Data type
text
Alias
- UMLS CUI [1]
- C1548329
Description
comment
Data type
text
Alias
- UMLS CUI [1]
- C0947611
Description
Name
Data type
text
Alias
- UMLS CUI [1]
- C0027365
Description
Signature
Data type
text
Alias
- UMLS CUI [1]
- C1519316
Description
Date Submitted
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1515022
Similar models
CRF Tracking/ Review Form (TRF) Study Conclusion
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C1515022 (UMLS CUI [1,2])